Drug Prescribing Patterns in Geriatric Patients With Type 2 Diabetes Mellitus at a Tertiary Care Teaching Hospital: A Cross-Sectional Study
Deeksha Gupta, Anurag Sharma, Sartaj Hussain, K K Sawlani, Devendra Katiayar, Kauser Usman, Rajendra Nath

TL;DR
This study examines drug prescribing patterns in elderly patients with type 2 diabetes at a hospital in North India, finding high polypharmacy and suboptimal use of essential medicines.
Contribution
The study provides empirical evidence on prescribing practices in geriatric T2DM patients using WHO indicators in a real-world setting.
Findings
Average number of drugs per prescription was 5.22, indicating high polypharmacy.
Only 21% of prescribed drugs were from the National List of Essential Medicines.
Sulfonylureas were the most commonly prescribed antidiabetic drug class.
Abstract
Introduction Type 2 diabetes mellitus (T2DM) is highly prevalent among elderly individuals and is frequently accompanied by multiple comorbidities, resulting in complex pharmacotherapy and an increased risk of polypharmacy and irrational prescribing. Evaluating real-world prescribing patterns using standardized indicators is essential to promote rational drug use and optimize therapeutic outcomes in geriatric patients with T2DM. Methods A hospital-based, cross-sectional observational study was conducted over one year (April 2024 to March 2025) in the outpatient department of a tertiary care teaching hospital in North India. A total of 600 geriatric patients (≥60 years) with T2DM were included. Demographic and clinical data were recorded using a predesigned case record form. Prescriptions were analyzed using World Health Organization (WHO) core prescribing indicators. Polypharmacy was…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsPharmaceutical Practices and Patient Outcomes · Antibiotic Use and Resistance · Chronic Disease Management Strategies
